Patient Safety Perspective

• The New Obesity Breakthrough Drugs I'm not using the term breakthrough lightly.
  Medscape, December 14, 2022
• Medscape Nurse Career Satisfaction Report 2022 Are nurses happy in their jobs? They share their experiences with abuse, burnout, and COVID vaccinations.
  Medscape Features Slideshows, December 09, 2022
• AACR 2022 New Data for Melanoma Patients Who Progress After PD-1 Blockade   Dr Jeffrey Weber discusses potential new approaches to managing melanoma patients who progress after anti-PD-1 agents.
  Medscape Oncology, December 08, 2022
• Put the Patient First in Managing Hyperglycemia   The patient needs to come first in managing hyperglycemia, says Dr Anne Peters, who provides guidance on providing care particularly for patients in underresourced settings.
  Medscape Diabetes & Endocrinology, December 08, 2022
• Nurses Questions Answered: Could You Face Repercussions for Your Actions? An experienced nurse discusses what repercussions nurses could face when raising concerns about staffing, safety and other workplace issues that impact their jobs and patient care.
  Medscape Nurses, December 08, 2022
• Right or Wrong in Medicine: Tricky Patient Situations Physicians reveal how they would choose in difficult decisions and scenarios involving patient interactions that test both professional and personal relationships.
  Medscape Features Slideshows, December 07, 2022
• Cultural Differences Drive Kids' Thyroid Cancer Management The lack of supporting evidence in the management of pediatric differentiated thyroid carcinoma means cultural divergences and expert opinion drive the differences between US and European guidelines.
  Medscape Diabetes & Endocrinology, December 07, 2022
• It's Right to Discipline Docs Spreading False Info About COVID   Professor Art Caplan discusses potential repercussions for medical professionals who spread misinformation about COVID-19.
  Medscape Business of Medicine, December 07, 2022
• The Oncologist's Ethical Dilemma Medical professionals often face ethical challenges. Learn about how oncologists might navigate the four major pillars of medicine and when a lack of medical intervention may be justifiable.
  Medscape Blogs, December 06, 2022
• Episode 6: Challenges and Opportunities: Moderate to Severe Childhood Asthma   Drs Wechsler, Bacharier, and Phipatanakul discuss the challenges and opportunities in the field of moderate to severe childhood asthma.
  Medscape, December 06, 2022
• Lipid Management: The Ins and Outs of Inclisiran   Christopher V. DeSimone, MD, PhD, and Stephen L. Kopecky, MD, discuss lipid management and the use of inclisiran, an siRNA drug that inhibits the RNA from making PCSK9.
  Mayo Clinic, December 05, 2022
• Top 10 Unproven Infertility Tests and Treatments Mark P. Trolice, MD, discusses popular but unproven fertility methods.
  MDedge, December 01, 2022
• NPs and Physicians: The Changing Scope of Practice Nurse practitioners (NPs) discuss their evolving professional relationships with physicians and shifting boundaries in practice responsibilities.
  Medscape Features Slideshows, November 30, 2022
• EASD 2022 New Studies Change Beliefs About Cardiovascular Disease   From timing of medications to supplement use, Dr Anne Peters reviews several recent studies that have changed beliefs in the realm of cardiovascular disease.
  Medscape Diabetes & Endocrinology, November 29, 2022
• The Surprising Failure of Vitamin D in Deficient Kids   Another vitamin D supplementation trial fails to impress, this time in kids with low levels. F. Perry Wilson argues that a new approach might be needed.
  Medscape, November 29, 2022
• 5 Things to Know About This Early Flu Season In the past 2 years there was relatively little flu activity, but this time the US is experiencing an early and potentially harsh flu season.
  CDC Expert Commentary, November 28, 2022
• Alcohol, Melatonin, and Other Top Clinical Topics of 2022 See which studies led to the most popular clinical topics of the year, with an infographic on each of the key findings.
  Medscape, November 28, 2022
• 'First Step' Toward Delaying Progression of Type 1 Diabetes   Dr Anne Peters discusses the approval of teplizumab and its potential impact in delaying the onset of stage 3 diabetes for patients age 8 years or older who currently have stage 2 type 1 diabetes.
  Medscape Diabetes & Endocrinology, November 22, 2022
• Starting Lamotrigine: Who Needs an EKG?   Drs Wilner and French discuss the latest FDA label changes on lamotrigine and what they mean in practice.
  Medscape Neurology, November 22, 2022
• Are Joint Commission Safety Rules Really Backed by Evidence?   Dr Alok Patel discusses the Joint Commission and the associated requirements for accreditation.
  Medscape Hospital Medicine, November 16, 2022